Study of Rimonabant/Metformin Combinations to Investigate Diabetes (Blood Sugar) Control in Patients With Type 2 Diabetes

Stopped Company decision taken in light of demands by certain national health authorities

Conditions

• Diabetes Mellitus, Type 2

Interventions

• DRUG: Rimonabant
• DRUG: Metformin
• DRUG: placebo

Sponsor

Sanofi